Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?

Recent studies indicate that cancer antigen 125 (CA125) response criteria tend to overestimate a tumour reduction measured by standard WHO response criteria in recurrent epithelial ovarian carcinoma. The aim of the study was to validate the recently introduced GCIG (The Gynaecological Cancer Intergr...

Full description

Saved in:
Bibliographic Details
Main Authors: Gronlund, B, Hansen, H H, Høgdall, C, Høgdall, E V S, Engelholm, S A
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2004
Subjects:
Clinical
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409573/
https://ncbi.nlm.nih.gov/pubmed/14735180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601501
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items